Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director comp.
Director departure
Bioventus Inc. (BVS) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/08/2023 8-K Quarterly results
Docs: "Bioventus Reports Second Quarter Financial"
06/09/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "BIOVENTUS INC. 2023 RETENTION EQUITY AWARD PLAN",
"BIOVENTUS INC. 2023 RETENTION EQUITY AWARD PLAN"
05/26/2023 8-K Completion of Acquisition or Disposition of Assets, Other Events, Financial Statements and Exhibits  Interact...
Docs: "Bioventus Completes Divestiture of",
"UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION"
05/16/2023 8-K Quarterly results
Docs: "Bioventus Reports First Quarter Financial Results"
05/16/2023 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits  Inte...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Asset Purchase Agreement, by and among Misonix, LLC, Solsys Medical, LLC, Bioventus LLC and LifeNet Health",
"Bioventus Announces Divestiture of its Wound Business"
05/11/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Bioventus Reschedules Earnings Call to May 16, 2023 Files for Extension to File Form 10-Q for the Period Ended April 1, 2023"
04/05/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Separation Agreement and Release between Kenneth Reali and Bioventus Inc."
03/31/2023 8-K Quarterly results
Docs: "Bioventus Reports Fourth Quarter and Full-Year 2022 Financial Results"
02/28/2023 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
01/09/2023 8-K Quarterly results
12/07/2022 8-K Cost Associated with Exit or Disposal Activities  Interactive Data
11/21/2022 8-K/A Quarterly results
Docs: "Bioventus Issues Revised Third Quarter Results&#59; Updates Full-Year 2022 Financial Guidance"
11/16/2022 8-K Quarterly results
Docs: "Bioventus Files for Extension to File Form 10-Q for the Period Ended October 1, 2022"
11/08/2022 8-K Quarterly results
Docs: "Bioventus Reports Third Quarter Results&#59; Updates Full-Year 2022 Financial Guidance"
09/27/2022 8-K/A Financial Statements and Exhibits  Interactive Data
Docs: "CONSENT OF INDEPENDENT ACCOUNTANTS",
"CARTIHEAL LTD. 2021 CONSOLIDATED FINANCIAL STATEMENTS",
"UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION"
08/31/2022 8-K Resignation/termination of a director
08/11/2022 8-K Quarterly results
07/12/2022 8-K Quarterly results
06/29/2022 8-K Quarterly results
06/22/2022 8-K Quarterly results
06/21/2022 8-K Quarterly results
05/10/2022 8-K Quarterly results
04/26/2022 8-K Results of Operations and Financial Condition, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits ...
Docs: "Bioventus Announces Preliminary First Quarter Net Sales and Adjusted EBITDA",
"Bioventus Announces $415 Million Offering of Senior Notes",
"UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION"
04/04/2022 8-K Other Events  Interactive Data
03/10/2022 8-K Quarterly results
02/28/2022 8-K Quarterly results
02/25/2022 8-K Regulation FD Disclosure  Interactive Data
01/12/2022 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Bioventus Announces Preliminary Fourth Quarter and Full-Year 2021 Revenue"
12/27/2021 8-K Resignation/termination of a director
11/22/2021 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "LEASE"
11/17/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
11/09/2021 8-K Quarterly results
Docs: "Bioventus Reports Third Quarter Results&#59; Updates Full-Year 2021 Financial Guidance"
10/29/2021 8-K Director compensation was amended/approved
Docs: "Amendment No. 2 to Credit and Guaranty Agreement, by and among Bioventus LLC, Oyster Merger Sub I, Inc., Oyster Merger Sub II, LLC, Misonix, Inc., certain Guarantor Subsidiaries party thereto, Wells Fargo Bank, National Association, as administrative agent, and the lenders and other financial institutions party thereto",
"Bioventus Completes the Acquisition of Misonix"
10/26/2021 8-K Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits &...
Docs: "Bioventus and Misonix Stockholders Approve the Acquisition of Misonix by Bioventus"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy